The vision of The Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy is to become a leader in the field of human immunology by establishing an environment where basic, translational and clinical aspects of human immunology and immunotherapy research are seamlessly integrated. We will achieve this through these primary initiatives:
- Facilitate basic research in the new and rapidly evolving areas of human immunology;
- Use the insights that emerge from this research to achieve a better understanding of human disease; and,
- Provide an environment that encourages and supports the clinical translation of these insights into novel therapies for autoimmunity, cancer, immunodeficiency and infectious diseases.
Bursky Center Faculty Membership
As a member of CHiiPs, you have full access to the Immunomonitoring Lab (IML), experts in cytometry and immunoassay production, and extensive resources; even better, CHiiPs members receive a substantial discounted rate for some of these services.
Upcoming Events
Please contact Yuko Morima at yuko@wustl.edu for questions or inclusion of additional events.
Just-In-Time (JIT) Core Usage Funding Program
The Just-In-Time (JIT) Core Usage Funding Program is designed to provide quick access to funding to use any of the JIT Cores for research advancing medical knowledge that can improve human health. The program provides support for investigators in obtaining final data that: Find out more and apply on the Institute of Clinical and Translational Scienc
Dr. Ali Ellebedy and multi-institution, multidisciplinary team awarded $13M by NIH to develop better vaccines against coronaviruses (Links to an external site)
The National Institute of Allergy and Infectious Diseases has awarded the Icahn School of Medicine at Mount Sinai a five-year, $13 million grant to bring together experts from multiple disciplines across five research institutions to create better vaccines against current as well as emerging coronaviruses. The “Programming Long-lasting Immunity to Coronaviruses” (PLUTO) project will be […]
Dr. Gwendalyn Randolph selected for new National Commission for Lymphatic Diseases (Links to an external site)
Gwendalyn Randolph, PhD, Emil R. Unanue Professor of Pathology and Immunology in the Division of Immunobiology, was chosen to be a member of the newly formed National Commission for Lymphatic Diseases. The Commission, which is slated for an inaugural meeting in December 2023, will be convened by NHLBI leadership. In 2022, Congress directed the NIH to […]
Every gift, no matter the size, helps supports our mission.
Thank you for your generous support!